Adam Morgan - 30 Jan 2026 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Adam Morgan
Issuer symbol
HRTX
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 09:15:29 UTC
Previous filing
12 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morgan Adam Director 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/ Adam Morgan 03 Feb 2026 0001964335

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +53,960 +77% $0.000000 123,737 30 Jan 2026 Direct F1
holding HRTX Common Stock 8,753,290 30 Jan 2026 By Velan Capital Master Fund LP F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Securities owned directly by Velan Capital Master Fund LP ("Velan Master"). Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.